MedPage Today on MSN
Study questions benefit of FDA-cleared device for ADHD
The agency is currently reviewing the study findings ...
While proven a safe method, external trigeminal nerve stimulation was nonsuperior to sham treatment as early as 4 weeks and as long as 6 months in children and adolescents with ADHD, according to data ...
A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.
Thomas Cooper was five years old when he died while receiving an alternative treatment for ADHD and sleep apnoea. The boy from Royal Oak, Michigan, had been taken by his parents to receive hyperbaric ...
Study Finds on MSN
FDA-cleared brain stimulation device for ADHD works no better than placebo in major trial
In A Nutshell • A brain stimulation device cleared by the FDA in 2019 failed to beat placebo in a rigorous 150-participant ...
Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...
The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...
In a multicenter randomized trial of 150 children and adolescents, trigeminal nerve stimulation failed to outperform sham ...
“Importantly, there is currently no funding allocation to GPs and primary health care to cover GP training and diagnosis of ADHD - it sits outside our current public funding model. So time spent on ...
The number of UK adults taking medication for Attention-Deficit Hyperactivity Disorder (ADHD) has risen twenty-fold since ...
For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...
This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results